AI & Data Analytics

The tech can help identify Mabry syndrome. So what’s next?

"You need a mandate from the institutional leadership down that we’re going to makes this data accessible and usable to make progress."

John Mattison, MD, likes science fiction. Today, he warned of the scenarios that could emerge from unchecked AI.

A former IBM health researcher discussed why basing technologies like Watson on trials and guidelines would not work.

The physician and data scientist gave 7 important points that healthcare should keep in mind when implementing AI projects.

Technology allows people to screen for hereditary cancers. But what happens afterward?

The 4th edition of the annual competition keeps the focus on healthcare, calling on contestants to employ AI for cellular research.

The creator of a digital genetics database says it’s all about harmonization.

What healthcare must learn from a new analysis that doubles as a warning.

Experts and insiders sound off on the projects, people, and patterns poised to pop off in 2018.

Our editorial advisory board describes the hurdles and chances to overcome them.

Fear not the rise of the algorithms, Sawad Thotathil of Persistent Systems writes.

While positive behavioral change from wearable usage hasn’t been conclusively demonstrated, the value of the data they produce is indisputable.

The pairing comes on the heels of a $30 million fundraising round for the population health analytics firm.

How he hopes to further the growing telehealth company.

“I think our conference is unique in that we’re focused on more practical applications of artificial intelligence and machine learning."

Excel Medical calls the combined approval of a predictive algorithm and delivery platform "the first of its kind."

How the 2 titans plan to promote precision medicine.

The initiative is similar to the All of Us program being run by the National Institutes of Health in the United States

A new study tackles 3 vexing questions: Do humans have genes that enable regeneration, could they be used to fight cancer, and can AI find them?

Caltech researchers continue to refine the microscopic device, whose potential continues to grow.

The majority of the new funding comes from Chinese genomics giant iCarbonX.

How Michael Christman, PhD, left his mark on genomics and so much more.

John Giannouris knows that the pharmaceutical industry is changing.

Why the cutting-edge analytics firm is joining forces with Baptist Health South Florida's year-old cancer center.